| 样本编号 | SAMC1677567 |
|---|---|
| 外部数据库编号 | GSA-Human: HRS285828 |
| 样品名称 | Sample375 |
| 样本标题 | Panel sequencing of P064_6 |
| 样品类型 | Human sample |
| 物种名称 | Homo sapiens |
| 描述信息 | Targeted sequencing of tumor samples of P064_6 |
| 样本属性 | *该样本包含更多受控访问信息，请通过GSA-Human系统申请项目HRA001346数据获取。 |
| 发布日期 | 2021-09-23 |
| 项目编号 | PRJCA005206 |
| 提交者 | xian zhang (guowei@cicams.ac.cn) |
| 提交单位 | Geneseeq Technology Inc. |
| 提交日期 | 2023-06-18 |
| 资源名称 | 描述 |
|---|---|
| GSA-Human (1) | - |
| HRA001346 (Controlled Access) | Accurately evaluating minimal residual disease (MRD) could facilitate early intervention and personalized adjuvant therapies. Here, using ultradeep targeted next-generation sequencing (NGS), we evaluated the clinical utility of circulating tumor DNA (ctDNA) for dynamic recurrence risk and adjuvant chemotherapy (ACT) benefit prediction in resected non-small cell lung cancer (NSCLC). |